Sensum+ Clinical Studies

Status

Published

on 2 Jan 2019

Year of Creation

2014

Innovus Pharmaceuticals, Inc

Registration Number

TX0008672337

on 2 Jan 2019

The U.S. Copyright record (Registration Number: TX0008672337) dated 2 Jan 2019, pertains to an electronic file (eService) titled "Sensum+ Clinical Studies" created in 2014. The copyright holder is Innovus Pharmaceuticals, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Innovus Pharmaceuticals, Inc.

Innovus Pharmaceuticals, Inc

Application Details

Registration Number

TX0008672337

Registration Date

1/2/2019

Year of Creation

2014

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Innovus Pharmaceuticals, Inc

Physical Description

Electronic file (eService)

First Publication Nation

United States

Corporate Authors

Inc Innovus Pharmaceuticals

Notes

Rights Note: Randy Berholtz, Innovus Pharmaceuticals, Inc., 8845 Rehco Road, San Diego, CA, 92121, United States, (858) 249-7873, rberholtz@innovuspharma.com

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Sensum+ Clinical Studies

Author Statement: Innovus Pharmaceuticals, Inc employer for hire Citizenship: United States Authorship: text

Notes

Rights Note: Randy Berholtz, Innovus Pharmaceuticals, Inc., 8845 Rehco Road, San Diego, CA, 92121, United States, (858) 249-7873, rberholtz@innovuspharma.com

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Sensum+ Clinical Studies

Author Statement: Innovus Pharmaceuticals, Inc employer for hire Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.